Natalija Dedić Plavetić | Charles Explorer

Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approach

2022 | Publikace bez příslušnosti k fakultě